U.S. and allied demand for attritable, NDAA-compliant small UAS and layered C-UAS is shifting from prototype budgets to production. Army SRR (Red Cat Black Widow), AVAV Switchblade / Puma scale, RTX Coyote interceptor buys, and FY2027 C-UAS budget language (~$14.4B proposed to defend against unmanned threats, per IDGA/summit reporting — verify in the actual FY27 request) create a multi-year procurement upcycle. Domestic component substitution (UMAC and peers) is a policy tailwind after NDAA foreign-drone restrictions and Blue UAS / DCMA list expansion.
Research desk
U.S. drone & counter-UAS equities
Educational decision-support for U.S.-listed names with material drone, C-UAS, component, or autonomy exposure. Not advice. Last print Nov 11, 2:37 PM EST · Yahoo Finance spark (query1).
Universe
11
9 excluded
Total mkt cap
$783.7B
Shares × last print
Median Q YoY
+116%
Reported quarters only
Median GM
25%
Where disclosed
Unprofitable
2
Cash runway often n.d.
Disclosed backlog
$2.4B
Do not sum unlike items
Drone products
10
Yes or partial
C-UAS capability
8
Yes or partial
Maritime / USV
6
Yes or partial
China exposure flag
1
Direct or indirect
DoD-linked awards
5
In this contract set
Named integrations
2
Anduril / Palantir / Skydio / Shield
Five working books
Open the setRanked for research intensity — funded production, converting backlog, or a live program of record. Not the whole universe.
01 · Quality core
AVAV
The only scaled U.S. tactical UAS + loitering-munition franchise with a funded $1.2B backlog and FY27 guide.
02 · Scaled attritable
KTOS
The only public attritable-jet UAS with funded production lots, a USMC CCA role, and a cash-generative parent.
03 · Profitable converter
AVEX
Newly public U.S. tactical UAS manufacturer that is actually profitable, converting a real funded book, and trading under the IPO print.
04 · PoR convexity
RCAT
Army SRR program-of-record selectee. Tiny P&L, thin margin, real procurement path — the multiple is a funded-FRP option.
05 · C-UAS platform
ONDS
Only U.S. small-cap in this universe that is both a drone OEM and a C-UAS interceptor, with $1.4B cash — and a dilution story to match.
Analyst heat map
1–5. Risk columns inverted (5 = more risk).
Revenue accrues to a handful of validated platforms (AVAV, RTX Coyote, Army PoR winners, Kratos Valkyrie lots) while most small-cap names remain order-book and dilution stories. Backlog converts unevenly; IDIQ ceilings are not sales. Multiples compress as 2025–26 speculative rerates fade (AVAV 52-week high $417 vs ~$148). Survivors are those with funded production, not press-release partnerships.
Appropriations slip, LRIP/FRP awards lag, or a single large program is re-competed (SRR, LIDS, Replicator follow-ons). Small caps fund growth with ATM / follow-ons (ONDS share count 381M → 571M in eight months). China-cost hardware remains a commercial alternative. Primes internalize C-UAS. Several DRNZ constituents are non-U.S. or non-defense and do not validate a U.S. industrial-base thesis.
Industry bottlenecks
- NDAA-compliant motors, radios, batteries, GNSS, and EO/IR still have thin U.S. capacity.
- Blue UAS / DCMA list throughput — DIU-to-DCMA transition (memo targeting 1 Jan 2026) is a process risk, not a product risk.
- Attritable production: airframes are easier than secure C2, munitions integration, and quality systems that DCMA will accept.
- Kill-chain software (track, ID, fire-control) is concentrated in primes and a few software firms.
- Test ranges, spectrum, and airworthiness for Group 1–3 remain slow relative to Ukraine-tempo expectations.
What would invalidate
- SRR or LIDS recompete / cancellation.
- Evidence that reported backlog is unfunded, cancelled, or concentrated in a single export customer.
- A U.S. policy reversal reopening DJI-class systems for federal use.
- Sustained ATM issuance that outruns revenue growth (ONDS, UMAC, RCAT).
- A prime offering a cheap interceptor that prices Coyote / VAMPIRE / Iron Drone out of the stack.